Markets:

Overview

News

Currencies

International

Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

30.36 -1.04 (-3.32%)

Streaming Delayed Price Updated: 3:17 PM EST, Jan 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

29 30 Next >

Missed Out on Eli Lilly's 480% Gains Over the Past 5 Years? These GLP-1 Stocks Still Have Plenty of Upside. ↗

June 18, 2025

Via The Motley Fool

Are These 2 High-Flying Growth Stocks Still Worth Buying After Recent Pullbacks? ↗

June 16, 2025

Via The Motley Fool

Topics Government

10 Health Care Stocks Whale Activity In Today's Session ↗

June 10, 2025

Via Benzinga

1 Stock Down 34% This Year to Buy and Hold ↗

June 08, 2025

Via The Motley Fool

Earnings Scheduled For April 23, 2025 ↗

April 23, 2025

Via Benzinga

Earnings Preview For Viking Therapeutics ↗

April 22, 2025

Via Benzinga

How Is The Market Feeling About Viking Therapeutics? ↗

April 21, 2025

Via Benzinga

Could Viking Therapeutics Become the Next Eli Lilly? ↗

June 02, 2025

Via The Motley Fool

3 Best Growth Stocks to Buy in June ↗

June 02, 2025

Via The Motley Fool

Topics Artificial Intelligence Economy Government

Better Weight Loss Stock: Amgen or Viking Therapeutics? ↗

May 22, 2025

Via The Motley Fool

Why Viking Therapeutics Stock Bumped 3% Higher Today ↗

May 16, 2025

Via The Motley Fool

Novo Nordisk Sheds 4% After Ousting CEO As Eli Lilly Rivalry Slams Stock Price ↗

May 16, 2025

Novo Nordisk said Friday it will replace its CEO, citing a sharp tumble for Novo shares amid growing competition.

Via Investor's Business Daily

Why Weight-Loss Developer Stocks Tumbled on Tuesday ↗

May 13, 2025

Via The Motley Fool

Topics Government

2 Monster Stocks in the Making to Buy Now and Hold for 10 Years ↗

May 13, 2025

Via The Motley Fool

3 Monster Stocks in the Making ↗

May 11, 2025

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 09, 2025

Via Benzinga

Down Nearly 20%: Should You Buy the Dip on Eli Lilly? ↗

May 08, 2025

Via The Motley Fool

Topics Earnings Government World Trade

Why Viking Therapeutics Stock Surged Nearly 20% Higher in April ↗

May 06, 2025

Via The Motley Fool

Why Viking Therapeutics Stock Was Victorious This Week ↗

May 02, 2025

Via The Motley Fool

Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday ↗

May 02, 2025

GLP-1 drug prices are falling. That's good news for patients, but perhaps not such good news for pharmaceutical stock investors.

Via The Motley Fool

Topics World Trade

Is Novo Nordisk Stock a Buy? ↗

May 02, 2025

Via The Motley Fool

Where Will Viking Therapeutics Be in 3 Years? ↗

May 02, 2025

Viking's leading drug candidate could be a blockbuster in the weight loss market, which experts believe could grow to $150 billion over the coming years.

Via The Motley Fool

Topics Bankruptcy

1 Beaten-Down Stock to Buy and Hold for 10 Years ↗

May 01, 2025

Via The Motley Fool

Topics Economy

Will Pfizer Will Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback? ↗

April 30, 2025

Via The Motley Fool

Prediction: Pfizer's Loss May Be Viking Therapeutics' Gain ↗

April 30, 2025

Via The Motley Fool

Why Viking Therapeutics Stock Popped Again Today ↗

April 29, 2025

Cantor Fitzgerald thinks the GLP-1 diet drug VK2735 will be a "multi-blockbuster" for Viking stock.

Via The Motley Fool

Why Viking Therapeutics Stock Popped Today ↗

April 28, 2025

2025 is the year we learn whether Viking Therapeutics stock will be a winner.

Via The Motley Fool

Viking Therapeutics Stock May Struggle After As-Expected Report

April 25, 2025

Viking Therapeutics stock is trying to push higher as investors attempt to sort out a report that delivered no real news that investors hadn’t already heard.

Via MarketBeat

Viking Therapeutics Stock Dips After Q1 EPS Miss: Details ↗

April 23, 2025

Viking Therapeutics releases its first-quarter results after Wednesday's closing bell. Here's a look at the details from the report.

Via Benzinga

A Look At Viking Therapeutics VKTX ↗

April 21, 2025

While we wait for the earnings report to be posted along with the forward guidance predictions, the chart looks interesting.

Via Talk Markets

Topics Stocks / Equities

< Previous 1 2 3 4 5 6 7 8 9

...

29 30 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.